CITI/CALL/PFIZER INC/46/0.1/20.06.24 Stock

Warrant

DE000KG5YBB4

Market Closed - Börse Stuttgart 03:05:03 2024-06-14 EDT
0.001 EUR 0.00% Intraday chart for CITI/CALL/PFIZER INC/46/0.1/20.06.24
6 months-80.00%
Current year-83.33%
Date Price Change
24-06-14 0.001 0.00%
24-06-13 0.001 0.00%
24-06-12 0.001 0.00%
24-06-11 0.001 0.00%
24-06-10 0.001 0.00%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 03:05 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Citi Citi
WKN KG5YBB
ISINDE000KG5YBB4
Date issued 2022-07-26
Strike 46 $
Maturity 2024-06-20 (4 Days)
Parity 10 : 1
Emission price 1.04
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.17
Lowest since issue 0.001

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.53 USD
Average target price
31.92 USD
Spread / Average Target
+15.93%
Consensus